SEOVF (Sernova Biotherapeutics) Dividends per Share : $0.00 (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Dividends per Share?

Sernova Biotherapeutics's dividends per share for the three months ended in Jan. 2025 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jan. 2025 was $0.00. Its Dividend Payout Ratio for the three months ended in Jan. 2025 was 0.00. As of today, Sernova Biotherapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sernova Biotherapeutics Dividends per Share Historical Data

The historical data trend for Sernova Biotherapeutics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Dividends per Share Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Dividends per Share

Get a 7-Day Free Trial

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova Biotherapeutics's Dividends per Share

For the Biotechnology subindustry, Sernova Biotherapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Sernova Biotherapeutics Dividends per Share Calculation

Dividends paid to per common share.

Sernova Biotherapeutics (OTCPK:SEOVF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Sernova Biotherapeutics's Dividend Payout Ratio for the quarter that ended in Jan. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2025 )	/	EPS without NRI (Q: Jan. 2025 )
	=	0	/	-0.013
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Sernova Biotherapeutics Dividends per Share Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (OTCPK:SEOVF) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.